These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 34040258)

  • 21. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
    Daginakatte GC; Gianino SM; Zhao NW; Parsadanian AS; Gutmann DH
    Cancer Res; 2008 Dec; 68(24):10358-66. PubMed ID: 19074905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients.
    Hutter S; Piro RM; Waszak SM; Kehrer-Sawatzki H; Friedrich RE; Lassaletta A; Witt O; Korbel JO; Lichter P; Schuhmann MU; Pfister SM; Tabori U; Mautner VF; Jones DTW
    Hum Genet; 2016 May; 135(5):469-475. PubMed ID: 26969325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma.
    Bolcekova A; Nemethova M; Zatkova A; Hlinkova K; Pozgayova S; Hlavata A; Kadasi L; Durovcikova D; Gerinec A; Husakova K; Pavlovicova Z; Holobrada M; Kovacs L; Ilencikova D
    Neoplasma; 2013; 60(6):655-65. PubMed ID: 23906300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
    J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.
    Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH
    Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
    Brown JA; Emnett RJ; White CR; Yuede CM; Conyers SB; O'Malley KL; Wozniak DF; Gutmann DH
    Hum Mol Genet; 2010 Nov; 19(22):4515-28. PubMed ID: 20826448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.
    Jecrois ES; Zheng W; Bornhorst M; Li Y; Treisman DM; Muguyo D; Huynh S; Andrew SF; Wang Y; Jiang J; Pierce BR; Mao H; Krause MK; Friend A; Nadal-Nicolas F; Stasheff SF; Li W; Zong H; Packer RJ; Zhu Y
    Dev Cell; 2021 Oct; 56(20):2871-2885.e6. PubMed ID: 34428430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic characterization of an aggressive optic nerve pilocytic glioma.
    Hong CS; Fliney G; Fisayo A; An Y; Gopal PP; Omuro A; Pointdujour-Lim R; Erson-Omay EZ; Omay SB
    Brain Tumor Pathol; 2021 Jan; 38(1):59-63. PubMed ID: 33098465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibromin in the brain.
    Gutmann DH
    J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects.
    Tang Y; Gutmann DH
    Cancer Manag Res; 2023; 15():667-681. PubMed ID: 37465080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
    Kocova M; Kochova E; Sukarova-Angelovska E
    BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
    Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
    Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.
    Pong WW; Higer SB; Gianino SM; Emnett RJ; Gutmann DH
    Ann Neurol; 2013 Feb; 73(2):303-8. PubMed ID: 23424002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey.
    Sharafi P; Varan A; Ersoy-Evans S; Ayter S
    Childs Nerv Syst; 2024 Feb; 40(2):511-515. PubMed ID: 37401974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM
    Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human stem cell modeling in neurofibromatosis type 1 (NF1).
    Wegscheid ML; Anastasaki C; Gutmann DH
    Exp Neurol; 2018 Jan; 299(Pt B):270-280. PubMed ID: 28392281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.
    Brossier NM; Thondapu S; Cobb OM; Dahiya S; Gutmann DH
    Neuro Oncol; 2021 Apr; 23(4):625-637. PubMed ID: 33080011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
    Diggs-Andrews KA; Brown JA; Gianino SM; Rubin JB; Wozniak DF; Gutmann DH
    Ann Neurol; 2014 Feb; 75(2):309-16. PubMed ID: 24375753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.